Keywords: crestor, ezetimibe, reduce, crp, levels, cd, study

Crestor and ezetimibe reduce CRP levels in CD study

Article | 11 September 2006

Print This

Data from a study of AstraZeneca's Crestor (rosuvastatin), show that the drug, in combination with ezetimibe, brought about a 46% reduction ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in